S

S2Medical AB (publ)
STO:S2M

Watchlist Manager
S2Medical AB (publ)
STO:S2M
Watchlist
Price: 0.0093 SEK
Market Cap: kr8.4m

Relative Value

The Relative Value of one S2M stock under the Base Case scenario is hidden SEK. Compared to the current market price of 0.0093 SEK, S2Medical AB (publ) is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

S2M Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

S2M Competitors Multiples
S2Medical AB (publ) Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
S2Medical AB (publ)
STO:S2M
8.4m SEK 0.6 -0.8 -5.4 -2.8
JP
Hoya Corp
TSE:7741
9.5T JPY 10.4 37.9 27.5 33
US
Medline Inc
NASDAQ:MDLN
56.1B USD 0 0 0 0
CH
Alcon AG
SIX:ALC
29B CHF 3.6 37.9 14.6 28.4
DK
Coloplast A/S
CSE:COLO B
97.6B DKK 3.5 24.5 12.9 15.4
US
Align Technology Inc
NASDAQ:ALGN
12.9B USD 3.2 31.4 13.5 18.6
UK
ConvaTec Group PLC
LSE:CTEC
4.4B GBP 2.4 33.4 11.7 18.2
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
39.2B CNY 8.6 23.8 21.4 21.4
JP
Asahi Intecc Co Ltd
TSE:7747
870B JPY 6.7 49.2 23.2 31.6
CA
Bausch + Lomb Corp
NYSE:BLCO
5.7B USD 1.1 -15.7 16.9 54.8
CN
Intco Medical Technology Co Ltd
SZSE:300677
37.6B CNY 3.8 22.1 32.8 32.8
P/E Multiple
Earnings Growth PEG
SE
S
S2Medical AB (publ)
STO:S2M
Average P/E: 32.5
Negative Multiple: -0.8
N/A N/A
JP
Hoya Corp
TSE:7741
37.9
14%
2.7
US
M
Medline Inc
NASDAQ:MDLN
Not Available
29%
N/A
CH
Alcon AG
SIX:ALC
37.9
32%
1.2
DK
Coloplast A/S
CSE:COLO B
24.5
21%
1.2
US
Align Technology Inc
NASDAQ:ALGN
31.4
34%
0.9
UK
ConvaTec Group PLC
LSE:CTEC
33.4
41%
0.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.8
9%
2.6
JP
A
Asahi Intecc Co Ltd
TSE:7747
49.2
38%
1.3
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -15.7 N/A N/A
CN
Intco Medical Technology Co Ltd
SZSE:300677
22.1
12%
1.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
S
S2Medical AB (publ)
STO:S2M
Average EV/EBITDA: 19.4
Negative Multiple: -5.4
N/A N/A
JP
Hoya Corp
TSE:7741
27.5
12%
2.3
US
M
Medline Inc
NASDAQ:MDLN
Not Available
9%
N/A
CH
Alcon AG
SIX:ALC
14.6
9%
1.6
DK
Coloplast A/S
CSE:COLO B
12.9
6%
2.2
US
Align Technology Inc
NASDAQ:ALGN
13.5
14%
1
UK
ConvaTec Group PLC
LSE:CTEC
11.7
11%
1.1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
21.4
13%
1.6
JP
A
Asahi Intecc Co Ltd
TSE:7747
23.2
12%
1.9
CA
Bausch + Lomb Corp
NYSE:BLCO
16.9
29%
0.6
CN
Intco Medical Technology Co Ltd
SZSE:300677
32.8
51%
0.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SE
S
S2Medical AB (publ)
STO:S2M
Average EV/EBIT: 28.2
Negative Multiple: -2.8
N/A N/A
JP
Hoya Corp
TSE:7741
33
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available
18%
N/A
CH
Alcon AG
SIX:ALC
28.4
26%
1.1
DK
Coloplast A/S
CSE:COLO B
15.4
7%
2.2
US
Align Technology Inc
NASDAQ:ALGN
18.6
21%
0.9
UK
ConvaTec Group PLC
LSE:CTEC
18.2
21%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
21.4
10%
2.1
JP
A
Asahi Intecc Co Ltd
TSE:7747
31.6
N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
54.8
72%
0.8
CN
Intco Medical Technology Co Ltd
SZSE:300677
32.8
24%
1.4
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett